SCHEMBL26850396

SCHEMBL26850396

CC(C)C1C2CN(CCO)CC21

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 4/20 0.36
MAPK1 P28482 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24315713 0.80 GBA1 (0.37) GBA1
SCHEMBL26147481 0.80 GBA1 (0.33) GBA1
SCHEMBL14752147 0.77 GBA1 (0.38) GBA1MAPK1KDM4EALDH1A1
SCHEMBL26790067 0.75 GBA1 (0.42) GBA1
SCHEMBL26147484 0.75 ELANE (0.31)
SCHEMBL18820447 0.75 MAPK1 (0.37) GBA1MAPK1KDM4EALDH1A1
SCHEMBL18174952 0.75 ATM (0.35)
SCHEMBL27053499 0.74 KDM1A (0.33)
SCHEMBL22784412 0.71
SCHEMBL22784166 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220137-A1 PYRAZINE DERIVATIVES AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2023-11-16 WO disclosed